Brennan, Paul Anthony

Track

Insider profile

Performance

Overall performance
3.3
Performance over holding periods
3.3
30 days 90 days 120 days
Average return 12% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Brennan, Paul Anthony's trades of Eupraxia Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-11-26 2025-11-24
B Purchase
3,932 -23.3%
46.26
CA$2,337,933 		3,932 -23.3% 46.26 CA$2,337,933
2025-11-26 2025-11-24
B Purchase
91,078 +27.5%
327.27
CA$1,315,659 		91,078 +27.5% 327.27 CA$1,315,659
2025-11-26 2025-11-24
B Purchase
42,745 -0.2%
121.20
CA$73,131 		42,745 -0.2% 121.20 CA$73,131
2025-11-26 2025-11-24
B Purchase
4,800 +17.6%
8.80
CA$42,240 		4,800 +17.6% 8.80 CA$42,240
2023-08-20 2023-08-18
B Purchase
5,000 +22.5%
7.00
CA$35,000 		5,000 +22.5% 7.00 CA$35,000